Ma Liang, Cao Yongyue, Jiang Yongwei, Cong Xiao, Lu Shuang, Shen Jun, Liu Qian, Han Chengwu, Zhan Yuliang, Cao Yongtong
Clin Lab. 2016 Oct 1;62(10):2065-2072. doi: 10.7754/Clin.Lab.2016.160326.
FLT3-internal tandem duplication mutations (ITDs) are found in approximately 30% of patients with acute myeloid leukemia (AML) and are markers of poor prognosis. However, the characteristics of FLT3/ ITDs in Chinese AML patients have rarely been reported. The aim of this study was to analyze the frequency and characteristics of FLT3/ITDs in Chinese AML patients.
In the selected 152 cases of Chinese AML patients, capillary electrophoresis (CE) was used to analyze the frequency and characteristics of FLT3/ITDs. Next-generation sequencing was used to analyze the sequences of FLT3/ITDs positive patients. The differences of clinical features between FLT3/ITD positive group and FLT3/ITD negative group were estimated by statistical analysis.
42 cases (27.6%) were FLT3/ITDs-positive, in which 34 cases (81%) had a single duplication, and the remaining 8 cases (19%) had 2 or more ITDs. Median ITD size was 42 bp and median ITD allelic ratio was 0.25. Using next-generation sequencing, ITDs integrating in non-juxtamembrane (JM) domains were detected in 12 ITDs (24%) and in JM domains were detected in 38 ITDs (76%). Furthermore, duplication of at least one residue between Y591 and Y599 was detected in 48 (96%) of all 50 ITDs, and the insertion site was strongly correlated with ITD size: more C-terminal located inserted fragments were significantly longer.
Our data provide further evidence of the heterogeneity of FLT3/ITDs among different subgroups in Chinese AML patients. ITDs varied widely, but hotspots were concentrated. These results also suggest that nextgeneration sequencing is a useful method for detection of FLT3/ITDs sequences.
约30%的急性髓系白血病(AML)患者存在FLT3内部串联重复突变(ITD),这些突变是预后不良的标志物。然而,中国AML患者中FLT3/ITD的特征鲜有报道。本研究旨在分析中国AML患者中FLT3/ITD的频率及特征。
选取152例中国AML患者,采用毛细管电泳(CE)分析FLT3/ITD的频率及特征。对FLT3/ITD阳性患者进行二代测序分析其序列。通过统计分析评估FLT3/ITD阳性组与阴性组临床特征的差异。
42例(27.6%)患者FLT3/ITD阳性,其中34例(81%)为单重复,其余8例(19%)有2个或更多ITD。ITD的中位大小为42 bp,中位ITD等位基因比例为0.25。采用二代测序,在12个ITD(24%)中检测到整合在非近膜(JM)结构域的ITD,在38个ITD(76%)中检测到整合在JM结构域的ITD。此外,在所有50个ITD中的48个(96%)检测到Y591和Y599之间至少有一个残基重复,且插入位点与ITD大小密切相关:位于更C端的插入片段明显更长。
我们的数据进一步证明了中国AML患者不同亚组中FLT3/ITD的异质性。ITD差异很大,但热点集中。这些结果还表明二代测序是检测FLT3/ITD序列的有效方法。